XERS
Xeris Pharmaceuticals Inc
9.10$
-1.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,320.0% | 1,402.5% | 0.7% | 4,523.5% | 2,060.4% | 16.0% | 1,599.3% | 2,666.7% | 5.2% | 0.0% | 7.2% | 3.1% | 86.0% | 100.1% | 64.1% | 30.0% | 47.5% | 22.3% | 38.0% | 29.2% | 22.6% | 28.4% | 19.0% | 17.7% | 19.0% | 16.0% | 19.9% | 17.0% | 23.2% | 14.7% | 21.8% | 25.0% | 15.8% | 14.5% | 20.4% | 14.8% | 22.2% | 16.0% | 13.6% | 16.7% | |
| 99.3% | 100.0% | 99.3% | 100.0% | 100.0% | 84.0% | 100.0% | 100.0% | 94.8% | 100.0% | 92.8% | 96.9% | 14.0% | -0.1% | 35.9% | 70.0% | 52.5% | 77.7% | 62.0% | 70.8% | 77.4% | 71.6% | 81.0% | 82.3% | 81.0% | 84.0% | 80.1% | 83.0% | 76.8% | 85.3% | 78.2% | 75.0% | 84.2% | 85.5% | 79.6% | 85.2% | 77.8% | 84.0% | 86.4% | 83.3% | |
| 952.4% | 1,034.5% | 743.5% | 3,367.6% | 1,408.6% | 3,312.5% | 1,059.5% | 1,868.6% | 1,546.8% | 5,309.3% | 6,041.6% | 4,804.3% | 666.3% | 371.7% | 260.9% | 41.0% | 71.2% | 49.2% | 60.4% | 51.3% | 46.5% | 28.3% | 14.7% | 20.3% | 14.9% | 14.6% | 16.0% | 10.4% | 14.4% | 19.2% | 12.0% | 10.8% | 10.1% | 12.9% | 11.3% | 10.1% | 9.2% | 10.6% | 11.6% | 10.4% | |
| 377.7% | 378.8% | 275.9% | 1,186.5% | 663.4% | 1,231.6% | 549.3% | 799.0% | 1,089.3% | 5,047.6% | 4,695.0% | 4,605.9% | 1,107.4% | 1,208.4% | 870.4% | 174.5% | 250.9% | 219.6% | 291.1% | 240.5% | 250.0% | 162.7% | 130.3% | 116.0% | 103.7% | 101.2% | 99.0% | 77.2% | 84.6% | 94.4% | 83.2% | 82.9% | 66.8% | 73.2% | 62.1% | 62.5% | 55.4% | 63.9% | 66.3% | 62.1% | |
| 1,330.8% | 1,413.3% | 1,019.5% | 4,554.1% | 2,071.9% | 4,544.1% | 1,608.8% | 2,667.5% | 2,636.1% | 10,356.9% | 10,736.6% | 9,410.2% | 1,773.7% | 1,580.1% | 1,131.4% | 215.5% | 322.2% | 282.0% | 351.6% | 291.6% | 300.2% | 203.3% | 155.7% | 145.5% | 126.8% | 124.0% | 122.2% | 93.2% | 99.0% | 120.4% | 95.2% | 98.7% | 81.4% | 90.6% | 73.3% | 76.2% | 58.2% | 74.5% | 80.8% | 72.4% | |
| -1,230.8% | -1,313.3% | -920.2% | -4,454.1% | -1,971.9% | -4,460.1% | -1,508.8% | -2,567.5% | -2,536.1% | -10,256.9% | -10,643.8% | -9,313.3% | -1,759.7% | -1,580.2% | -1,095.5% | -145.5% | -269.7% | -204.3% | -289.5% | -220.7% | -222.8% | -131.7% | -74.7% | -63.2% | -45.8% | -40.0% | -42.0% | -10.2% | -22.2% | -35.1% | -17.0% | -23.8% | 2.8% | -5.1% | 6.3% | 9.0% | 19.5% | 9.5% | 5.6% | 10.9% | |
| 0.2% | 0.3% | 0.2% | 112.9% | 0.2% | 72.6% | 68.6% | 126.6% | 131.7% | 428.6% | 331.9% | 1,085.8% | 82.1% | 83.8% | 110.6% | 24.6% | 64.0% | 21.9% | 20.2% | 16.3% | 8.3% | 16.0% | 13.6% | 13.4% | 13.2% | 18.7% | 17.2% | 14.2% | 15.8% | 17.3% | 16.6% | 14.3% | 12.8% | 12.2% | 10.3% | 9.8% | 8.3% | 8.3% | 7.5% | 8.4% | |
| -1,228.7% | -1,313.3% | -926.0% | -4,427.6% | -1,958.5% | -4,527.4% | -1,585.7% | -2,537.3% | -2,549.2% | -10,192.3% | -10,745.3% | -10,165.9% | -1,799.4% | -1,632.2% | -1,194.3% | -169.3% | -304.8% | -224.7% | -308.9% | -235.7% | -234.4% | -154.6% | -104.8% | -74.6% | -40.0% | -50.7% | -54.0% | -25.9% | -30.7% | -45.9% | -29.7% | -35.1% | -8.5% | -15.3% | -2.7% | 0.8% | 12.9% | 2.7% | -33.8% | -5.1% | |
| 0.0% | 0.0% | 0.2% | 26.5% | 0.0% | 72.6% | 59.1% | 126.6% | 110.0% | 428.6% | 331.9% | 1,085.8% | -24.6% | 65.9% | -5.4% | 20.6% | 57.8% | 21.9% | 20.2% | 16.3% | 8.3% | -1.8% | -1.3% | -1.1% | -1.0% | 8.3% | -1.8% | -0.7% | -0.5% | 0.8% | 1.6% | -6.1% | – | – | – | – | – | – | – | – | |
| -1,228.7% | -1,313.3% | -926.0% | -4,427.6% | -1,958.5% | -4,527.4% | -1,585.7% | -2,537.3% | -2,549.2% | -10,192.3% | -10,745.3% | -10,165.9% | -1,774.8% | -1,632.2% | -1,188.9% | -169.3% | -304.8% | -224.7% | -308.9% | -235.7% | -234.4% | -152.7% | -103.5% | -73.4% | -39.0% | -50.7% | -52.2% | -25.2% | -30.2% | -46.7% | -31.2% | -29.0% | -8.5% | -15.3% | -2.7% | 0.8% | 12.9% | 2.7% | -33.8% | -5.1% | |
| – | -1,302.5% | -914.3% | -4,423.5% | -1,946.7% | -4,430.8% | -1,507.6% | -2,409.8% | -2,395.8% | -9,709.7% | -10,343.1% | -8,975.2% | -1,696.8% | -1,530.5% | -1,068.0% | -140.7% | -234.5% | -198.7% | -285.2% | -216.5% | -222.0% | -124.9% | -79.1% | -50.8% | -16.3% | -22.4% | -28.0% | -4.8% | -7.5% | -20.7% | -6.5% | -15.0% | 9.5% | 2.0% | 12.0% | 14.9% | 16.5% | 14.8% | -22.9% | 4.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.